Last reviewed · How we verify

NCT06171529: CTM CMC

Efficacy of a Single Injection of CTM for Post-Operative CMC Arthritis

Status unknown NA Last updated 28 March 2024
What this trial tests

NA trial testing CTM in Osteoarthritis in 50 participants. Status unknown.

Timeline
7 March 2023
Primary endpoint
31 December 2025
31 January 2026

Quick facts

Lead sponsorIndiana Hand to Shoulder Center
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingdouble
Primary purposetreatment
Enrollment50
Start date7 March 2023
Primary completion31 December 2025
Estimated completion31 January 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Indiana Hand to Shoulder Center — full company profile →

Who can join

18 and older, any sex, with Osteoarthritis or Osteoarthritis Thumb Base Joint. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to determine the success rate of a single Carpometacarpal (CMC) thumb injection after arthroplasty surgery for primary osteoarthritis of the CMC joint.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of CTM

Trials testing the same drug.

Other recruiting trials for Osteoarthritis

Currently open trials in the same condition.

Other Indiana Hand to Shoulder Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06171529.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing